Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Non-Current Assets (2017 - 2025)

Catheter Precision (VTAK) has disclosed Non-Current Assets for 9 consecutive years, with $15.5 million as the latest value for Q4 2025.

  • Quarterly Non-Current Assets fell 36.8% to $15.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $85.9 million through Dec 2025, down 15.29% year-over-year, with the annual reading at $15.5 million for FY2025, 36.8% down from the prior year.
  • Non-Current Assets for Q4 2025 was $15.5 million at Catheter Precision, down from $23.0 million in the prior quarter.
  • The five-year high for Non-Current Assets was $35.8 million in Q1 2023, with the low at $1.9 million in Q3 2022.
  • Average Non-Current Assets over 5 years is $18.3 million, with a median of $23.7 million recorded in 2025.
  • The sharpest move saw Non-Current Assets plummeted 54.93% in 2022, then skyrocketed 1304.61% in 2023.
  • Over 5 years, Non-Current Assets stood at $4.0 million in 2021, then tumbled by 51.23% to $1.9 million in 2022, then soared by 1277.66% to $26.6 million in 2023, then dropped by 7.89% to $24.5 million in 2024, then tumbled by 36.8% to $15.5 million in 2025.
  • According to Business Quant data, Non-Current Assets over the past three periods came in at $15.5 million, $23.0 million, and $23.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.